Evaluating the prognostic value of cd56 in pediatric acute myeloid leukemia

HIGHLIGHTS

• who: Tianqi Liang from the All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the , HelsinkiThis study has been approved by the Ethic Committee of the Nanfang Hospital of Southern Medical University. Informed written consent was obtained from all of the children and/or parents before study inclusion. This retrospective cohort study enrolled , children newly diagnosed with AML (non-M3). Two patients were excluded due to loss to follow-up, and three patients did not complete induction chemotherapy. Ultimately, this research . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.